About
Berkeley Advanced Biomaterials (BAB), established in 1996 and located in Berkeley, California, specializes in manufacturing high-quality biomaterials for orthopedic and bone tissue engineering applications. The company is a licensed Tissue Bank accredited by the American Association of Tissue Banks, ensuring adherence to strict ethical and quality standards. BAB offers a diverse range of products, including allograft, synthetic, and bioactive materials designed for bone and soft tissue repair. Their synthetic offerings utilize nano-crystalline hydroxyapatite and purified collagen technologies, available in various forms such as granules, blocks, flexible strips, and injectable putty. Additionally, they provide pure human allograft products, including demineralized bone matrix putty and cancellous chips, tailored to meet specific surgical needs. The company also produces calcium-based materials like tricalcium phosphate and calcium sulfate for use in bioresorbable medical devices. Berkeley Advanced Biomaterials collaborates with healthcare providers, surgeons, and researchers to develop innovative biomaterial applications, focusing on improving patient outcomes and enhancing the experiences of healthcare professionals.
Technologies
Keywords
Company Information
-
Employees 20
-
Founded 1996
-
Annual Revenue $8000000
Location
2800 7th St, Berkeley, California, United States, 94710